Deaths from heart disease and stroke are declining, but still kill more Americans than any other cause, according to new data ...

GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are ...

By Tarun Sai Lomte From rising obesity and diabetes to stubborn health inequities, the AHA’s latest statistics reveal why ...

An AHA report shows 2023 heart and stroke deaths declined, yet both still lead U.S. mortality as major risks like ...

India, Jan. 25 -- Many misconceptions lead to body shaming of the Obese and the Skinny by ridiculing or mocking them, and ...

The new report examined numbers from 2023, the latest year for which data were available. Deaths from cardiovascular diseases totaled 916,000, including about 680,000 deaths from heart disease and 180 ...

OBESITY is a direct cause of dementia, say scientists. Flab has for years been known to be a risk for brain damage but ...

What began as diabetes therapy is fast becoming the backbone of a new era in medicine—one where obesity, heart disease, and metabolic disorders are treated at their biological roots.

Sedentary living raises diabetes, heart disease and mental health risks. Learn practical steps to reduce sitting time at work ...

Deaths from heart disease and stroke in the United States declined in 2023 after a five-year upward trend likely influenced by the COVID-19 pandemic, but the two conditions remain the nation’s leading ...

With COVID now out of the top 5, stroke has taken over the number 4 position thanks to rising death rates in young and old.

A new study reveals stopping GLP-1 weight loss drugs leads to rapid weight regain, nearly four times faster than quitting ...